DE69122805D1 - Antivirusmittel - Google Patents

Antivirusmittel

Info

Publication number
DE69122805D1
DE69122805D1 DE69122805T DE69122805T DE69122805D1 DE 69122805 D1 DE69122805 D1 DE 69122805D1 DE 69122805 T DE69122805 T DE 69122805T DE 69122805 T DE69122805 T DE 69122805T DE 69122805 D1 DE69122805 D1 DE 69122805D1
Authority
DE
Germany
Prior art keywords
antiviral agents
polysaccharide
chem
integer
active component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69122805T
Other languages
English (en)
Other versions
DE69122805T2 (de
Inventor
Katsushi Hagiwara
Mikio Kikuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taito Co Ltd
Original Assignee
Taito Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taito Co Ltd filed Critical Taito Co Ltd
Application granted granted Critical
Publication of DE69122805D1 publication Critical patent/DE69122805D1/de
Publication of DE69122805T2 publication Critical patent/DE69122805T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69122805T 1990-06-25 1991-06-18 Antivirusmittel Expired - Fee Related DE69122805T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2166251A JP2911554B2 (ja) 1990-06-25 1990-06-25 抗ウィルス剤

Publications (2)

Publication Number Publication Date
DE69122805D1 true DE69122805D1 (de) 1996-11-28
DE69122805T2 DE69122805T2 (de) 1997-04-03

Family

ID=15827923

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69122805T Expired - Fee Related DE69122805T2 (de) 1990-06-25 1991-06-18 Antivirusmittel

Country Status (11)

Country Link
US (1) US5320849A (de)
EP (1) EP0463540B1 (de)
JP (1) JP2911554B2 (de)
AT (1) ATE144426T1 (de)
AU (1) AU642023B2 (de)
CA (1) CA2045212C (de)
DE (1) DE69122805T2 (de)
DK (1) DK0463540T3 (de)
ES (1) ES2095884T3 (de)
GR (1) GR3022165T3 (de)
NZ (1) NZ238673A (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
US5811542A (en) * 1989-09-08 1998-09-22 Alpha-Beta Technology, Inc. Method for producing soluble glucans
US5488040A (en) * 1989-09-08 1996-01-30 Alpha-Beta Technology, Inc. Use of neutral soluble glucan preparations to stimulate platelet production
JPH05503952A (ja) * 1989-09-08 1993-06-24 アルファ　ベータ　テクノロジー，インコーポレイティッド 可溶性グルカン類の製造方法
GB9714102D0 (en) * 1997-07-04 1997-09-10 Ciba Geigy Ag Compounds
US6046323A (en) * 1997-07-29 2000-04-04 The Collaborative Group, Ltd. Conformations of PPG-glucan
US6251877B1 (en) * 1998-03-24 2001-06-26 Pacific Corporation Composition for external application containing a β-1,6-branched-β-1,3-glucan
AU6261999A (en) 1998-09-25 2000-04-17 Collaborative Group, Ltd., The Very high molecular weight beta-glucans
US6369216B1 (en) 1998-09-25 2002-04-09 Biopolymer Engineering Pharmaceutical, Inc. Very high molecular weight β-glucans
US7906492B2 (en) 2001-01-16 2011-03-15 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
US7507724B2 (en) 2001-01-16 2009-03-24 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
US7914799B2 (en) * 2001-08-27 2011-03-29 Immunitor USA, Inc. Anti-fungal composition
US7052712B2 (en) * 2001-10-05 2006-05-30 Rubicon Scientific Llc Animal feeds including actives and methods of preparing same
US6866862B2 (en) * 2001-10-05 2005-03-15 Rubicon Scientific Animal feeds including heartworm-prevention drugs
US6716448B2 (en) 2001-10-05 2004-04-06 Rubicon Scientific Llc Domesticated household pet food including maintenance amounts of ivermectin
EP1545208A4 (de) * 2002-08-13 2006-04-12 Biopolymer Engineering Inc Verfahren zur verwendung von beta-glucan als strahlenschutzmittel
US20060165700A1 (en) * 2002-09-04 2006-07-27 Ostroff Gary R Cancer therapy using whole glucan particles and antibodies
EP2181711A1 (de) * 2002-09-04 2010-05-05 Biopolymer Engineering, Inc. Krebstherapie mit ganzen Glukan-Teilchen und Antikörpern
US20040091579A1 (en) * 2002-11-13 2004-05-13 Rubicon Scientific Llc; Extruded foodstuffs having maintenance level actives
KR100419191B1 (ko) * 2003-06-23 2004-02-19 주식회사 엔바이오테크놀러지 독감 인플루엔자 바이러스 및 전염성 위장염 코로나바이러스 억제 활성을 갖는 효모변이주 아이에스2 유래수용성 글루칸 올리고머를 함유하는 조성물
US7197521B2 (en) * 2003-11-21 2007-03-27 Intel Corporation Method and system performing concurrently mark-sweep garbage collection invoking garbage collection thread to track and mark live objects in heap block using bit vector
US8323644B2 (en) 2006-01-17 2012-12-04 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
WO2013171137A1 (en) 2012-05-16 2013-11-21 Wintershall Holding GmbH Method for precipitating and re-dissolving beta-glucan
MX359669B (es) 2012-07-04 2018-10-05 Wintershall Holding GmbH Microorganismos modificados genéticamente capaces de producir beta-glucanos, y métodos para la producción de beta-glucanos.
CA2963603A1 (en) 2014-10-31 2016-05-06 Wintershall Holding GmbH Method for concentrating beta-glucans
US10273514B2 (en) 2014-12-04 2019-04-30 Wintershall Holding GmbH Method for preparing an aqueous solution of beta-glucan
KR20170089009A (ko) 2014-12-12 2017-08-02 빈터샬 홀딩 게엠베하 진균 균주의 발효 방법
WO2017055532A1 (en) 2015-10-02 2017-04-06 Wintershall Holding GmbH Redispersion of schizophyllan

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3943247A (en) * 1972-05-22 1976-03-09 Kaken Kagaku Kabushiki Kaisha Treatment of bacterial infections with glucan compositions
JPS5919121B2 (ja) * 1975-10-31 1984-05-02 タイトウ カブシキガイシヤ シンキノヤクリカツセイタトウブンカイブツノ セイゾウホウホウ
SE445013B (sv) * 1979-06-21 1986-05-26 Landstingens Inkopscentral Medel for att forebygga eller behandla infektioner hos menniskor och djur
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
JP2681653B2 (ja) * 1988-05-13 1997-11-26 台糖株式会社 抗エイズウィルス剤
FR2631829B1 (fr) * 1988-05-30 1992-04-03 Pasteur Institut Exopolysaccharides fongiques ayant une activite immunostimulante, leur procede d'obtention et composition therapeutique les contenant
JP2771178B2 (ja) * 1988-07-06 1998-07-02 日本電気アイシーマイコンシステム株式会社 除算回路
CA1330303C (en) * 1989-02-20 1994-06-21 Libor Henry Nikl Composition and process to enhance the efficacy of a fish vaccine
JPH062676B2 (ja) * 1989-02-20 1994-01-12 台糖株式会社 水溶性グルカンからなる魚病の予防剤

Also Published As

Publication number Publication date
JP2911554B2 (ja) 1999-06-23
DE69122805T2 (de) 1997-04-03
CA2045212A1 (en) 1991-12-26
CA2045212C (en) 1998-01-20
EP0463540A1 (de) 1992-01-02
GR3022165T3 (en) 1997-03-31
EP0463540B1 (de) 1996-10-23
DK0463540T3 (da) 1996-11-18
JPH0454124A (ja) 1992-02-21
AU7928991A (en) 1992-01-02
ES2095884T3 (es) 1997-03-01
ATE144426T1 (de) 1996-11-15
AU642023B2 (en) 1993-10-07
NZ238673A (en) 1992-07-28
US5320849A (en) 1994-06-14

Similar Documents

Publication Publication Date Title
DE69122805T2 (de) Antivirusmittel
FI914928A0 (fi) Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner.
DE68925155D1 (de) Verwendung von Halogenkohlenwasserstofflösungsmittel als Reinigungsmittel
IL96882A0 (en) Uracil derivatives and pesticides containing the same as active ingredient
ATE72448T1 (de) 2-alkynyladenosine als aktive bestandteile enthaltende antihypertensive mittel.
ES2175860T3 (es) Procedimiento quimico.
MX9203032A (es) Una solucion farmaceutica.
DE69331721T2 (de) Neue carbamazepin hapten Analoge
KR910700089A (ko) 히드로클로로플루오로프로판의 공비 조성물 또는 공비형 조성물
ES2093037T3 (es) Derivados de beta-lactama y su preparacion.
EA199900834A1 (ru) Антивирусные средства
ATE156486T1 (de) Fungizide 3,4-diaryl-(5h)-furan-2-onederivate
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
AU740079C (en) Antirheumatic agents
AU1491583A (en) Optically active imidazolylpropanols
ATE163005T1 (de) Saintopin derivate
ITMI912104A1 (it) Poliglucosidi da idrossialchilsorbitolo
TH5978A (th) อนุพันธ์ไดแซ็กคาไรด์
TH5978EX (th) อนุพันธ์ไดแซ็กคาไรด์
TH4572B (th) อนุพันธ์ไดแซ็กคาไรด์
TH11212EX (th) สารประกอบแคทไอออนิคและสารผสมสารทำความสะอาด

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee